Navigation Links
DARA BioSciences, Inc. and Point Therapeutics, Inc. Announce Consummation of Merger
Date:2/12/2008

RALEIGH, N.C. and WELLESLEY HILLS, Mass., Feb. 12 /PRNewswire/ -- DARA BioSciences, Inc. ("DARA") and Point Therapeutics, Inc. ("Point") (Nasdaq: POTP) announced the consummation of their merger transaction, effective as of the close of business on February 12, 2008.

The merger was completed after approval by the respective stockholders of DARA and Point. Immediately prior to the consummation of the merger, Point effected a reverse stock split of its common stock pursuant to which each 40 shares of Point common stock issued and outstanding was converted into one share of Point common stock. As a result of the merger, DARA stockholders will receive 1.031406 shares of Point common stock for each share of DARA common stock and preferred stock held immediately prior to the transaction.

In making the announcement, DARA's Chairman Richard A. Franco, Sr., commented, "We are pleased to have completed this transaction and appreciate the confidence of the stockholders of DARA and Point as evidenced by their votes."

Upon consummation of the merger, DARA became a wholly-owned subsidiary of Point, and Point changed its name to DARA BioSciences, Inc. The combined company's common stock will continue to trade on the NASDAQ Capital Market under the symbol "DARA ". Additionally, the Board of Directors and executive officers of DARA will lead the combined company.

About DARA BioSciences, Inc.

DARA BioSciences(TM), Inc. ("DARA") is a Raleigh, North Carolina-based development-stage pharmaceutical company that acquires promising therapeutic molecules and medical technologies directly or through investment in established companies. DARA focuses its therapeutic development efforts on small molecules from late preclinical development through phase 2 clinical trials. DARA is developing a portfolio of therapeutic candidates for neuropathic pain, metabolic diseases including type 2 diabetes, and dermatological disorders. DARA has licensed promising drug development candidates from Kirin Pharmaceuticals of Japan, Bayer Pharmaceuticals Corporation, Massachusetts General Hospital and Nuada LLC.

As of February 13, 2008, DARA will trade on the NASDAQ Capital Market under the ticker symbol "DARA".

For more information please contact the Company at 919-872-5578 or visit our web site at http://www.darabiosciences.com.


'/>"/>
SOURCE DARA BioSciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Pressure BioSciences, Inc. Reports Third Quarter 2007 Financial Results and Provides Business Update
2. Pressure BioSciences, Inc. to Discuss Third Quarter Financial Results and Provide Business Update
3. Akers Biosciences, Inc. ABI or the Company Receipt of Further United States Military Contracts
4. Jill Birkett Appointed Event Director for HBA Global Expo
5. USHEALTH Group Announces Appointment of Executive Vice President
6. ScienceBased Health Appoints Anne L. Coleman, MD, PhD to Scientific Advisory Board
7. Protalix BioTherapeutics Appoints Professor Roger D. Kornberg to Board of Directors
8. AMN Healthcare Appoints Hala Moddelmog to Its Board of Directors
9. Natural Alternatives International, Inc. Appoints New Chief Financial Officer
10. Deerfield Spa Appoints New Fitness Director
11. Memory Pharmaceuticals Appoints Vaughn M. Kailian Interim President & Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/16/2018)... CLARA, Calif. (PRWEB) , ... November 16, 2018 ... ... has announced the launch of a new corridor from Canada to India. The ... Kingdom. , According to the Canadian International Development Platform, in 2016, an estimated ...
(Date:11/16/2018)... ... ... Opioid drugs are commonly prescribed for back pain and other chronic pain. They work by ... problem with these drugs, however, is that they are very addictive. In fact, statistics from ... more than 130 people per day died as a result of opioid drug overdose. ...
(Date:11/15/2018)... BOTHELL, Wash. (PRWEB) , ... November 15, 2018 ... ... natural health and cosmetic benefits of acupuncture available to people in an accessible ... growing health and wellness franchise in the nation, opening locations all across the ...
(Date:11/15/2018)... ... 15, 2018 , ... Sift Healthcare, a revenue cycle intelligence ... investors including Wind River Financial, a Madison-based payment processing company. , The ... to provide a range of solutions for healthcare organizations including claims workflow intelligence, ...
(Date:11/15/2018)... ... November 15, 2018 , ... Drs. Randolph ... skilled medical professionals to join their team at Waldman, Schantz, Turner ... clinic, Skin Chic, and is expanding its staff to meet patient demand. These ...
Breaking Medicine News(10 mins):
(Date:11/17/2018)... ... ... The International Society of Hair Restoration (ISHRS) recently held the 26th ... The event, held in Hollywood, California from October 10th-14th, was chaired by Dr. Parsa ... founder of Parsa Mohebi Hair Restoration in Los Angeles, “my first step ...
(Date:11/17/2018)... (PRWEB) , ... November 17, 2018 , ... Dr. Sundardas, ... lead you through a path of discovery finding your vision and clarity about your ... toward reaching your goals, expanding your productivity, purpose, and the joy in your life. ...
(Date:11/16/2018)... ... November 16, 2018 , ... ... addition of University Veterinary Specialists (UVS), now known as MedVet Pittsburgh. The City ... MedVet looks forward to providing local veterinarians continued support and access to specialty ...
Breaking Medicine Technology: